A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection
Clinical trial NCT02593851 · TERMINATED
Trial details
- NCT number
- NCT02593851
- Sponsor
- Janssen Sciences Ireland UC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-04
- Primary completion
- 2017-03-21
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.